Q4 2025 · 13F-HR
22NW, LPholdings as filed
Filed 2026-02-13 · accession 0001214659-26-001725
$237.6M
Reported value
20
Positions
2025-12-31
Period end
The Brief · 22NW, LP · Q4 2025
AI · grounded in 13F
22NW, LP closed its position in DHX, reducing its exposure by $5.66M. The fund also exited its position in AEBI for a reduction of $4.34M. To offset these sells, the fund established a new position in NSP valued at $3.73M and increased its holdings in MEC by 3.6%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $84.8M | 35.7% | 15,467,300 | Common | SOLE |
| 350060109 | FSTR | FOSTER L B CO | $32.1M | 13.5% | 1,191,046 | Common | SOLE |
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $23.0M | 9.69% | 1,254 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $14.0M | 5.89% | 331,115 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $13.3M | 5.60% | 923,679 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $13.0M | 5.47% | 358,325 | Common | SOLE |
| 86183P102 | SRI | STONERIDGE INC | $12.7M | 5.34% | 2,192,764 | Common | SOLE |
| 578605107 | MEC | MAYVILLE ENGR CO INC | $7.8M | 3.26% | 414,280 | Common | SOLE |
| 230215105 | CULP | CULP INC | $6.6M | 2.79% | 1,859,061 | Common | SOLE |
| 71742W103 | PFX | PHENIXFIN CORP | $5.2M | 2.19% | 117,885 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $4.7M | 1.96% | 586,519 | Common | SOLE |
| 218683100 | CMT | CORE MOLDING TECHNOLOGIES | $4.5M | 1.88% | 222,738 | Common | SOLE |
| 45778Q107 | NSP | INSPERITY INC | $3.7M | 1.57% | 96,300 | Common | SOLE |
| 904677200 | UFI | UNIFI INC | $3.0M | 1.26% | 852,455 | Common | SOLE |
| 307675108 | FB1 | FARMER BROS CO | $2.9M | 1.20% | 1,955,526 | Common | SOLE |
| 878155308 | TISI | TEAM INC | $2.4M | 1.01% | 170,187 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.9M | 0.82% | 820,653 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $960,910 | 0.40% | 636,364 | Common | SOLE |
| 86272A305 | SSKN | STRATA SKIN SCIENCES INC | $676,614 | 0.28% | 536,995 | Common | SOLE |
| 744375304 | — | PSYCHEMEDICS CORPORATION CMN | $441,654 | 0.19% | 276,034 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.